307 related articles for article (PubMed ID: 24308784)
21. Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase Deficiency.
Mehta N; Gilbert R; Chahal PS; Moreno MJ; Nassoury N; Coulombe N; Lytvyn V; Mercier M; Fatehi D; Lin W; Harvey EM; Zhang LH; Nazemi-Moghaddam N; Elahi SM; Ross CJD; Stanimirovic DB; Hayden MR
Hum Gene Ther; 2023 Sep; 34(17-18):927-946. PubMed ID: 37597209
[TBL] [Abstract][Full Text] [Related]
22. Biosafety of recombinant adeno-associated virus vectors.
Dismuke DJ; Tenenbaum L; Samulski RJ
Curr Gene Ther; 2013 Dec; 13(6):434-52. PubMed ID: 24195602
[TBL] [Abstract][Full Text] [Related]
23. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy using adeno-associated virus vectors.
Daya S; Berns KI
Clin Microbiol Rev; 2008 Oct; 21(4):583-93. PubMed ID: 18854481
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
Serguera C; Bemelmans AP
Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
[TBL] [Abstract][Full Text] [Related]
26. Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union.
Ylä-Herttuala S
Mol Ther; 2012 Oct; 20(10):1831-2. PubMed ID: 23023051
[No Abstract] [Full Text] [Related]
27. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
Flannery JG; Visel M
Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
[TBL] [Abstract][Full Text] [Related]
28. [Recombinant adeno-associated virus vector related impurities].
Diao Y; Wang Q; Xiao W; Xu R
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
[TBL] [Abstract][Full Text] [Related]
29. Considerations for Preclinical Safety Assessment of Adeno-Associated Virus Gene Therapy Products.
Assaf BT; Whiteley LO
Toxicol Pathol; 2018 Dec; 46(8):1020-1027. PubMed ID: 30295175
[TBL] [Abstract][Full Text] [Related]
30. Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions.
Masat E; Pavani G; Mingozzi F
Discov Med; 2013 Jun; 15(85):379-89. PubMed ID: 23819952
[TBL] [Abstract][Full Text] [Related]
31. [Adeno-associated viral vectors: methods for production and purification for gene therapy applications].
Mena-Enriquez M; Flores-Contreras L; Armendáriz-Borunda J
Rev Invest Clin; 2012; 64(5):487-94. PubMed ID: 23544311
[TBL] [Abstract][Full Text] [Related]
32. Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.
Gruntman AM; Flotte TR
Hum Gene Ther Methods; 2015 Jun; 26(3):77-81. PubMed ID: 26067712
[TBL] [Abstract][Full Text] [Related]
33. The rapidly evolving state of gene therapy.
Gruntman AM; Flotte TR
FASEB J; 2018 Apr; 32(4):1733-1740. PubMed ID: 31282760
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Rip J; Nierman MC; Sierts JA; Petersen W; Van den Oever K; Van Raalte D; Ross CJ; Hayden MR; Bakker AC; Dijkhuizen P; Hermens WT; Twisk J; Stroes E; Kastelein JJ; Kuivenhoven JA; Meulenberg JM
Hum Gene Ther; 2005 Nov; 16(11):1276-86. PubMed ID: 16259561
[TBL] [Abstract][Full Text] [Related]
35. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Zaiss AK; Muruve DA
Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
[TBL] [Abstract][Full Text] [Related]
36. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
Couto LB
Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
[TBL] [Abstract][Full Text] [Related]
37. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
[TBL] [Abstract][Full Text] [Related]
38. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases.
Berns KI; Srivastava A
Gastroenterol Clin North Am; 2019 Jun; 48(2):319-330. PubMed ID: 31046978
[TBL] [Abstract][Full Text] [Related]
39. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
40. Evolving AAV-delivered therapeutics towards ultimate cures.
He X; Urip BA; Zhang Z; Ngan CC; Feng B
J Mol Med (Berl); 2021 May; 99(5):593-617. PubMed ID: 33594520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
